NCT03959579View on ClinicalTrials.gov

"The no Biopsy Approach for Heart Transplantation Follow-up"

CompletedOBSERVATIONAL

Enrollment

269

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Cardiac Transplant Rejection

Interventions

DIAGNOSTIC_TEST

systematic endomyocardial biopsy.

"We sought to compare the long term survival of HTx recipients followed with or without systematic endomyocardial biopsy. Second, the sensibility and specificity of cardiac echo to diagnose acute allograft rejection will be analyzed.~To show the safety of non-invasively monitoring HTx recipients without systematic endomyocardial biopsy"

Trial Locations (1)

92350

Hopital Marie Lannelongue, Le Plessis-Robinson

All Listed Sponsors

lead

Centre Chirurgical Marie Lannelongue

OTHER

NCT03959579 - "The no Biopsy Approach for Heart Transplantation Follow-up" | Biotech Hunter | Biotech Hunter